Hrishikesh Belani • UCLA Profiles

Hrishikesh Kumar Belani

Title(s)	HS Associate Clinical Professor, Medicine
School	Medicine
vCard	Download vCard

Biography

Education and Training

Washington University in St. Louis, St. Louis, MO	AB	05/2004	Economics
Columbia University, New York, New York	MPH	05/2006	Health Policy and Management
University of Minnesota, Minneapolis, MN	MD	05/2013	Medicine
University of Colorado, Denver, CO		06/2016	Internal Medicine Residency

ORNG Applications

Clinical Trials

Featured Publications

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Implementation of Specialty Tobacco Use Disorder Services in a Community Health Setting: Support for Enhanced Prescription Practices. J Addict Med. 2023 Nov-Dec 01; 17(6):677-684. Meredith LR, Hurley B, Friedman TC, Lee ML, Rodriguez L, Lopez B, Mtume N, Dixon T, Belani HK, Hsieh S, Ray LA. PMID: 37934530.

View in: PubMed Mentions: Fields:
Sub Substance-Related Disorders
Translation:Humans PHPublic Health
Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. Lancet Infect Dis. 2023 10; 23(10):1119-1129. Bramante CT, Buse JB, Liebovitz DM, Nicklas JM, Puskarich MA, Cohen K, Belani HK, Anderson BJ, Huling JD, Tignanelli CJ, Thompson JL, Pullen M, Wirtz EL, Siegel LK, Proper JL, Odde DJ, Klatt NR, Sherwood NE, Lindberg SM, Karger AB, Beckman KB, Erickson SM, Fenno SL, Hartman KM, Rose MR, Mehta T, Patel B, Griffiths G, Bhat NS, Murray TA, Boulware DR, COVID-OUT Study Team. PMID: 37302406.

View in: PubMed Mentions: 12 Fields:
Com Communicable Diseases
Translation:Humans Cells CTClinical Trials
Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial. medRxiv. 2023 Jun 07. Bramante CT, Beckman KB, Mehta T, Karger AB, Odde DJ, Tignanelli CJ, Buse JB, Johnson DM, Watson RHB, Daniel JJ, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Siegel LK, Klatt NR, Anderson B, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Fricton RD, Lee S, Griffiths G, Pullen MF, Thompson JL, Sherwood N, Murray TA, Rose MR, Boulware DR, Huling JD. PMID: 37333243; PMCID: PMC10275003.

View in: PubMed Mentions:
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial. Clin Infect Dis. 2023 02 08; 76(3):e1-e9. Boulware DR, Murray TA, Proper JL, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Siegel LK, Klatt NR, Odde DJ, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Sherwood NE, Huling JD, Bramante CT, COVID-OUT study team. PMID: 36124697; PMCID: PMC9494422.

View in: PubMed Mentions: 5 Fields:
Com Communicable Diseases
Translation:Humans Cells PHPublic Health CTClinical Trials
Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up. medRxiv. 2022 Dec 23. Bramante CT, Buse JB, Liebovitz D, Nicklas J, Puskarich MA, Cohen K, Belani H, Anderson B, Huling JD, Tignanelli C, Thompson J, Pullen M, Siegel L, Proper J, Odde DJ, Klatt N, Sherwood N, Lindberg S, Wirtz EL, Karger A, Beckman K, Erickson S, Fenno S, Hartman K, Rose M, Patel B, Griffiths G, Bhat N, Murray TA, Boulware DR. PMID: 36597543; PMCID: PMC9810227.

View in: PubMed Mentions:
Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. N Engl J Med. 2022 08 18; 387(7):599-610. Bramante CT, Huling JD, Tignanelli CJ, Buse JB, Liebovitz DM, Nicklas JM, Cohen K, Puskarich MA, Belani HK, Proper JL, Siegel LK, Klatt NR, Odde DJ, Luke DG, Anderson B, Karger AB, Ingraham NE, Hartman KM, Rao V, Hagen AA, Patel B, Fenno SL, Avula N, Reddy NV, Erickson SM, Lindberg S, Fricton R, Lee S, Zaman A, Saveraid HG, Tordsen WJ, Pullen MF, Biros M, Sherwood NE, Thompson JL, Boulware DR, Murray TA, COVID-OUT Trial Team. PMID: 36070710; PMCID: PMC9945922.

View in: PubMed Mentions: 57 Fields:
Med Medicine (General)
Translation:Humans Cells CTClinical Trials
Harm reduction readiness for illicit IV drug use among safety-net primary care practices in the San Fernando Valley. Arch Public Health. 2022 Apr 06; 80(1):110. Kalinoski T, DeWitt C, Belani H. PMID: 35387678; PMCID: PMC8985360.

View in: PubMed Mentions:
Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms. Open Forum Infect Dis. 2022 May; 9(5):ofac066. Bramante CT, Proper JL, Boulware DR, Karger AB, Murray T, Rao V, Hagen A, Tignanelli CJ, Puskarich M, Cohen K, Liebovitz DM, Klatt NR, Broedlow C, Hartman KM, Nicklas J, Ibrahim S, Zaman A, Saveraid H, Belani H, Ingraham N, Christensen G, Siegel L, Sherwood NE, Fricton R, Lee S, Odde DJ, Buse JB, Huling JD. PMID: 35392460; PMCID: PMC8982774.

View in: PubMed Mentions: 9
Human papillomavirus vaccine acceptance among young men in Bangalore, India. Int J Dermatol. 2014 Nov; 53(11):e486-91. Belani HK, Sekar P, Guhaniyogi R, Abraham A, Bohjanen PR, Bohjanen K. PMID: 24961359; PMCID: PMC4205173.

View in: PubMed Mentions: 7 Fields:
Der Dermatology
Translation:Humans
HIV risk perception and behavior among sex workers in three major urban centers of Mozambique. PLoS One. 2014; 9(4):e94838. Langa J, Sousa C, Sidat M, Kroeger K, McLellan-Lemal E, Belani H, Patel S, Shodell D, Shodell M, Benech I, Needle R. PMID: 24736653; PMCID: PMC3988096.

View in: PubMed Mentions: 9 Fields:
Med Medicine (General)Sci Science
Translation:Humans
Neutrophilic urticaria with systemic inflammation: a case series. JAMA Dermatol. 2013 Apr; 149(4):453-8. Belani H, Gensler L, Bajpai U, Meinhardt E, Graf J, Pincus L, Leslie KS. PMID: 23715523.

View in: PubMed Mentions: 12 Fields:
Der Dermatology
Translation:Humans Cells
Sex, drugs, and HIV: rapid assessment of HIV risk behaviors among street-based drug using sex workers in Durban, South Africa. Soc Sci Med. 2008 Nov; 67(9):1447-55. Needle R, Kroeger K, Belani H, Achrekar A, Parry CD, Dewing S. PMID: 18678437.

View in: PubMed Mentions: 27 Fields:
Hea Health Services Soc Social Sciences
Translation:Humans